Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Strut Health vs Tell Her Doc

By GLP-1 ScorecardUpdated

Strut Health
Site position #28

Higher grade

Tell Her Doc
Site position #449

Lower grade

Score comparison

Strut Health has the higher recorded score — 79.4/100 to 57.4/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueStrut Health +62
90
28
Dose & formulationStrut Health +32
95
63
Clinical oversightTell Her Doc +21
55
76
Labs & monitoringStrut Health +8
60
52
FulfillmentStrut Health +5
88
83
Contract termsStrut Health +31
92
61
Strut Health · top barTell Her Doc · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricStrut HealthTell Her Doc
WeighScore79.4/10057.4/100
GradeC+C
Site position#28#449
SemaglutideOral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal$269/mo (microdose tier, plus a separate fee, compounded)
TirzepatideOral $199/30 days; injection $219/mo—confirm prescribed dose, quantity and renewalNot disclosed
CoverageFAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibilityAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Strut Health

Site position #28 · C+

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Strengths

  • Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
  • Provider consultations, follow-ups and shipping are advertised as included
  • Current help describes an account cancellation button; terms also provide an email route
  • Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription

What to consider

  • Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
  • Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
  • 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
  • Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Tell Her Doc

Site position #449 · C

Strengths

  • Full compounded GLP-1 lineup — semaglutide and tirzepatide in injection, oral and orally-dissolving-tablet forms, plus microdoses
  • Names its compounding pharmacy partner (Casa Pharma RX), which is independently listed in our pharmacy registry
  • No monthly membership, cancel anytime, free discreet shipping; HSA/FSA eligible with buy-now-pay-later plans
  • Serves patients in all 50 states via a private online consultation

What to consider

  • 'All sales are final' — no refunds once medication has left the pharmacy
  • Exact price is plan-dependent, shown after you pick a product; advertised 'starting at $269', with a lower $140 intro on oral semaglutide
  • References LegitScript but without an independently verifiable seal — we couldn't confirm certification
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Featured provider

Strut Health

Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard